Dam antidepressants

Jerod S. Denton

DOI: https://doi.org/10.1038/s41589-024-01567-8

IF: 14.8

2024-03-07

Nature Chemical Biology

Abstract:Kir4.1 potassium channels expressed in astroglial cells critically regulate extracellular potassium concentration in the brain. A new study reports that blocking the flow of potassium ions into astrocytes by inhibiting Kir4.1 induces rapid-onset antidepressive effects in rodents.

biochemistry & molecular biology

What problem does this paper attempt to address?

Regulation of gap junctional communication by astrocytic mitochondrial K(ATP) channels following neurotoxin administration in in vitro and in vivo models.

Kewen Jiang,Jiangping Wang,Congying Zhao,mei fu feng,zheng wu shen,Zhongsheng Yu,Zhezhi Xia

DOI: https://doi.org/10.1159/000323575

2011-01-01

Neurosignals

Abstract:It is known that neuronal ATP-sensitive potassium (K-ATP) channels and astrocytic gap junctions (GJs) are involved in the mechanism underlying neurodisorders. The K-ATP channels exist also in glial cells, and the objective of this study was to determine whether the astrocytic K-ATP channels exert their effect on neurotoxin-induced neurodysfunction through regulating the astrocytic GJ function. The results showed that diazoxide, a selective mitochondrial K-ATP (mitoK(ATP)) channel opener, enhanced the GJ coupling, but 5-hydroxydecanoate, a selective mitoK(ATP) channel blocker that significantly inhibits GJ coupling in vitro did not. Activation of astrocytic mitoK(ATP) channels alleviated kainic acid-induced dysfunction of GJ intercellular communication. Finally, activation of mitoK(ATP) channels improved the astrocytic GJ coupling in the hippocampus after seizures due to the colabeling of GJ subunit connexin 43 and connexin 45 with glial marker and was increased substantially by the administration of diazoxide. Western blot demonstrated that the mitoK(ATP) channels regulated the expression of connexin 43 (P2; active form) and connexin 45 in the epileptic hippocampus. These findings demonstrate that activation of astrocytic mitoK(ATP) channels improves the GJ function in astrocytes, indicating that the effect of the astrocytic mitoK(ATP) channels on neurotoxin-induced neurodysfunction might be, in part, through the regulation of the GJ-coupled spatial buffering in the hippocampus. Copyright (C) 2011 S. Karger AG, Basel
Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes

Yukihiro Ohno,Masato Kinboshi,Saki Shimizu

DOI: https://doi.org/10.3390/ijms19113313

IF: 5.6

2018-10-24

International Journal of Molecular Sciences

Abstract:Brain-derived neurotrophic factor (BDNF) is a key molecule essential for neural plasticity and development, and is implicated in the pathophysiology of various central nervous system (CNS) disorders. It is now documented that BDNF is synthesized not only in neurons, but also in astrocytes which actively regulate neuronal activities by forming tripartite synapses. Inwardly rectifying potassium (Kir) channel subunit Kir4.1, which is specifically expressed in astrocytes, constructs Kir4.1 and Kir4.1/5.1 channels, and mediates the spatial potassium (K+) buffering action of astrocytes. Recent evidence illustrates that Kir4.1 channels play important roles in bringing about the actions of antidepressant drugs and modulating BDNF expression in astrocytes. Although the precise mechanisms remain to be clarified, it seems likely that inhibition (down-regulation or blockade) of astrocytic Kir4.1 channels attenuates K+ buffering, increases neuronal excitability by elevating extracellular K+ and glutamate, and facilitates BDNF expression. Conversely, activation (up-regulation or opening) of Kir4.1 channels reduces neuronal excitability by lowering extracellular K+ and glutamate, and attenuates BDNF expression. Particularly, the former pathophysiological alterations seem to be important in epileptogenesis and pain sensitization, and the latter in the pathogenesis of depressive disorders. In this article, we review the functions of Kir4.1 channels, with a focus on their regulation of spatial K+ buffering and BDNF expression in astrocytes, and discuss the role of the astrocytic Kir4.1-BDNF system in modulating CNS disorders.

biochemistry & molecular biology,chemistry, multidisciplinary
Astrocytes Contribute to Regulation of Extracellular Calcium and Potassium in the Rat Cerebral Cortex During Spreading Depression

XY Lian,JL Stringer

DOI: https://doi.org/10.1016/j.brainres.2004.04.011

IF: 3.61

2004-01-01

Brain Research

Abstract:This study used spreading depression (SD), which is characterized by redistribution of ions, to examine the role of astrocytes in the regulation of extracellular potassium ([K+]o) and calcium ([Ca2+]o) levels. Recurrent spreading depression episodes were induced by application of 3 M potassium chloride to the cortex of adult anesthetized rats while monitoring the extracellular direct current (DC) potential shifts and changes in [K+]o or [Ca2+]o 6–7 mm away. The reversible glial toxins, fluorocitrate (FC) and fluoroacetate (FA), were injected locally into the cortex at doses that are selective for reducing glial function. The peak changes and area under the curve for [K+]o and [Ca2+]o, recovery rate for [K+]o, and interval between spreading depression episodes were measured before and at various times after administration of the toxins. Both fluorocitrate and fluroacetate slowed the recovery of the [K+]o and altered the recovery of the [Ca2+]o. Local injection of glutamate uptake inhibitors or barium had no effect on the peak changes in [K+]o or the rate of recovery of the [K+]o. The slowing of the recovery rate is consistent with the hypothesis that glial cells play a role in the return of [K+]o to baseline after spreading depression in the cortex in vivo. The change in movement of calcium after administration of FC suggests that astrocytes normally extrude calcium during spreading depression, resulting in rapid recovery of the levels of [Ca2+]o with an overshoot. These findings demonstrate that astrocytes contribute to the regulation of both potassium and calcium during and after a stress to the ionic homeostatic mechanisms.
Pharmacological Inhibition of Kir4.1 Evokes Rapid-Onset Antidepressant Responses

Xiaoyu Zhou,Cheng Zhao,Haiyan Xu,Yixiang Xu,Li Zhan,Pei Wang,Jingyi He,Taotao Lu,Yueling Gu,Yan Yang,Chanjuan Xu,Yiyang Chen,Yuxuan Liu,Yue Zeng,Fuyun Tian,Qian Chen,Xin Xie,Jianfeng Liu,Hailan Hu,Jian Li,Yueming Zheng,Jiangtao Guo,Zhaobing Gao

DOI: https://doi.org/10.1038/s41589-024-01555-y

IF: 14.8

2024-01-01

Nature Chemical Biology

Abstract:Major depressive disorder, a prevalent and severe psychiatric condition, necessitates development of new and fast-acting antidepressants. Genetic suppression of astrocytic inwardly rectifying potassium channel 4.1 (Kir4.1) in the lateral habenula ameliorates depression-like phenotypes in mice. However, Kir4.1 remains an elusive drug target for depression. Here, we discovered a series of Kir4.1 inhibitors through high-throughput screening. Lys05, the most potent one thus far, effectively suppressed native Kir4.1 channels while displaying high selectivity against established targets for rapid-onset antidepressants. Cryogenic-electron microscopy structures combined with electrophysiological characterizations revealed Lys05 directly binds in the central cavity of Kir4.1. Notably, a single dose of Lys05 reversed the Kir4.1-driven depression-like phenotype and exerted rapid-onset (as early as 1 hour) antidepressant actions in multiple canonical depression rodent models with efficacy comparable to that of (S)-ketamine. Overall, we provided a proof of concept that Kir4.1 is a promising target for rapid-onset antidepressant effects. Zhou et al. developed a specific small-molecule inhibitor of astrocytic Kir4.1 channels, Lys05, which exerts rapid-onset antidepressant effects in rodents without unwanted side effects, indicating Kir4.1 as a promising drug target.
Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression

Yihui Cui,Yan Yang,Zheyi Ni,Yiyan Dong,Guohong Cai,Alexandre Foncelle,Shuangshuang Ma,Kangning Sang,Siyang Tang,Yuezhou Li,Ying Shen,Hugues Berry,Shengxi Wu,Hailan Hu

DOI: https://doi.org/10.1038/nature25752

IF: 64.8

2018-02-15

Nature

Abstract:Increased expression of the potassium channel Kir4.1 on astrocytes in the lateral habenula drives neuronal bursting in rodent models of depression.

multidisciplinary sciences
Kir6.1/K-ATP channel in astrocytes is an essential negative modulator of astrocytic pyroptosis in mouse model of depression

Feng Li,Si-Yuan Jiang,Tian Tian,Wen-Jie Li,You Xue,Ren-Hong Du,Gang Hu,Ming Lu

DOI: https://doi.org/10.7150/thno.77455

IF: 11.6

2022-01-01

Theranostics

Abstract:Rationale: Astrocyte dysfunction is one of the important pathological mechanisms of depression. Stress contributes to the onset of depression. As metabolic stress sensor, Kir6.1-contaning K-ATP channel (Kir6.1/K-ATP) is prominently expressed in astrocytes. However, the involvement of Kir6.1/K-ATP channel in depression remains obscure. Methods: Astrocyte-specific Kir6.1 knockout mice were used to prepare two mouse models of depression to explore the role of astrocytic Kir6.1/K-ATP channel in depression. Primary astrocytes were cultured to reveal the underlying mechanism for Kir6.1-regulated astrocytic pyroptosis. Results: We identified that chronic stress reduced the astrocytic Kir6.1 expression in hippocampus of mice. We further observed astrocyte-specific knockout of Kir6.1 induced depressive-like behaviors in mice. Moreover, we found that astrocytic Kir6.1 deletion increased NLRP3-mediated astrocytic pyroptosis in response to stress. Mechanistically, Kir6.1 associated with NLRP3, and this interaction prevented the assembly and activation of NLRP3 inflammasome, thereby inhibition of astrocytic pyroptosis. More importantly, VX-765, an effective and selective inhibitor for NLRP3 inflammasome, could reverse the astrocytic pyroptosis and rescue the deterioration of behaviors in astrocytic Kir6.1 knockout mice. Conclusions: Our findings illustrate that Kir6.1/K-ATP channel in astrocytes is an essential negative modulator of astrocytic pyroptosis and plays a crucial role in depression and suggest that astrocytic Kir6.1/K-ATP channel may be a promising therapeutic target for depression.

medicine, research & experimental
Amoxapine Inhibits the Delayed Rectifier Outward K+ Current in Mouse Cortical Neurons Via Camp/protein Kinase A Pathways

Yan-Lin He,Xiao-Qin Zhan,Guang Yang,Ji Sun,Yan-Ai Mei

DOI: https://doi.org/10.1124/jpet.109.159160

2010-01-01

Journal of Pharmacology and Experimental Therapeutics

Abstract:Ion channels are known to be modulated by antidepressant drugs, but the molecular mechanisms are not known. We have shown that the antidepressant drug amoxapine suppresses rectifier outward K+ (I-K) currents in mouse cortical neurons. At a concentration of 10 to 500 mu M, amoxapine reversibly inhibited I-K in a dose-dependent manner and modulated both steady-state activation and inactivation properties. The application of forskolin or dibutyryl cAMP mimicked the inhibitory effect of amoxapine on I-K and abolished further inhibition by amoxapine. N-[2-(p-Bromocinnamylamino)ethyl]-5-iso-quinolinesulphonamide (H-89), a protein kinase A (PKA) inhibitor, augmented I-K amplitudes and completely eliminated amoxapine inhibition of I-K. Amoxapine was also found to significantly increase intracellular cAMP levels. The effects of amoxapine on I-K were abolished by preincubation with 5-hydroxytryptamine (5-HT) and the antagonists of 5-HT2 receptor. Moreover, intracellular application of guanosine 5'-[gamma thio]-triphosphate increased I-K amplitudes and prevented amoxapine-induced inhibition. The selective Kv2.1 subunit blocker Jingzhaotoxin-III reduced I-K amplitudes by 30% and also significantly abolished the inhibitory effect of amoxapine. Together these results suggest that amoxapine inhibits I-K in mouse cortical neurons by cAMP/PKA-dependent pathway associated with the 5-HT receptor, and suggest that the Kv2.1 alpha-subunit may be the target for this inhibition.
Lack of Rapid Antidepressant Effects of Kir4.1 Channel Inhibitors in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine.

Zhongwei Xiong,Kai Zhang,Tamaki Ishima,Qian Ren,Min Ma,Yaoyu Pu,Lijia Chang,Jincao Chen,Kenji Hashimoto

DOI: https://doi.org/10.1016/j.pbb.2018.11.010

2019-01-01

Abstract:A recent study demonstrated a key role of astroglial potassium channel Kir4.1 in the lateral habenula in depression. We investigated whether Kir4.1 protein is altered in the brain regions from susceptible mice after a chronic social defeat stress (CSDS). Furthermore, we compared the rapid and sustained antidepressant actions of Kir4.1 inhibitors (quinacrine and sertraline) and (R)-ketamine, (R)-enantiomer of rapid-acting antidepressant (R,S)-ketamine, in a CSDS model. Western blot analysis of Kir4.1 protein in the brain regions (prefrontal cortex, nucleus accumbens, hippocampus) from CSDS susceptible mice and control mice (no CSDS) was performed. Quinacrine (15, or 30 mg/kg), sertraline (20 mg/kg), (R)-ketamine (10 mg/kg), or vehicle was administered intraperitoneally to CSDS susceptible mice. Subsequently, locomotion test, tail suspension test (TST), forced swimming test (FST) and 1% sucrose preference test (SPT) were performed. There were no changes of Kir4.1 protein in the all regions between two groups. (R)-ketamine showed rapid and long-lasting antidepressant actions in CSDS susceptible mice. In contrast, quinacrine and sertraline did not attenuate the increased immobility time of TST and FST in CSDS susceptible mice. Furthermore, quinacrine and sertraline did not improve decreased sucrose preference of SPT in CSDS susceptible mice. Unlike (R)-ketamine, quinacrine and sertraline did not show rapid and sustained antidepressant effects in a CSDS model. Therefore, it is unlikely that Kir4.1 channel inhibitors may have ketamine-like robust antidepressant actions although further study using selective and potent Kir4.1 channel inhibitors is needed.
The Potassium Channel KCa3.1 Constitutes a Pharmacological Target for Astrogliosis Associated with Ischemia Stroke.

Mengni Yi,Tianjiao Wei,Yanxia Wang,Qin Lu,Gaoxian Chen,Xiaoling Gao,Herbert M. Geller,Hongzhuan Chen,Zhihua Yu

DOI: https://doi.org/10.1186/s12974-017-0973-8

IF: 9.3

2017-01-01

Journal of Neuroinflammation

Abstract:Reactive astrogliosis is one of the significantly pathological features in ischemic stroke accompanied with changes in gene expression, morphology, and proliferation. KCa3.1 was involved in TGF-β-induced astrogliosis in vitro and also contributed to astrogliosis-mediated neuroinflammation in neurodegeneration disease.
Inhibition of astroglial hemichannels prevents synaptic transmission decline during spreading depression

Juan E. Tichauer,Matías Lira,Waldo Cerpa,Juan A. Orellana,Juan C. Sáez,Maximiliano Rovegno

DOI: https://doi.org/10.1186/s40659-024-00519-9

2024-06-14

Biological Research

Abstract:Spreading depression (SD) is an intriguing phenomenon characterized by massive slow brain depolarizations that affect neurons and glial cells. This phenomenon is repetitive and produces a metabolic overload that increases secondary damage. However, the mechanisms associated with the initiation and propagation of SD are unknown. Multiple lines of evidence indicate that persistent and uncontrolled opening of hemichannels could participate in the pathogenesis and progression of several neurological disorders including acute brain injuries. Here, we explored the contribution of astroglial hemichannels composed of connexin-43 (Cx43) or pannexin-1 (Panx1) to SD evoked by high-K + stimulation in brain slices.

biology
Neuromodulation of Astrocytic K+ Clearance

Alba Bellot-Saez,Rebecca Stevenson,Orsolya Kékesi,Evgeniia Samokhina,Yuval Ben-Abu,John W Morley,Yossi Buskila

DOI: https://doi.org/10.3390/ijms22052520

2021-03-03

Abstract:Potassium homeostasis is fundamental for brain function. Therefore, effective removal of excessive K+ from the synaptic cleft during neuronal activity is paramount. Astrocytes play a key role in K+ clearance from the extracellular milieu using various mechanisms, including uptake via Kir channels and the Na+-K+ ATPase, and spatial buffering through the astrocytic gap-junction coupled network. Recently we showed that alterations in the concentrations of extracellular potassium ([K+]o) or impairments of the astrocytic clearance mechanism affect the resonance and oscillatory behavior of both the individual and networks of neurons. These results indicate that astrocytes have the potential to modulate neuronal network activity, however, the cellular effectors that may affect the astrocytic K+ clearance process are still unknown. In this study, we have investigated the impact of neuromodulators, which are known to mediate changes in network oscillatory behavior, on the astrocytic clearance process. Our results suggest that while some neuromodulators (5-HT; NA) might affect astrocytic spatial buffering via gap-junctions, others (DA; Histamine) primarily affect the uptake mechanism via Kir channels. These results suggest that neuromodulators can affect network oscillatory activity through parallel activation of both neurons and astrocytes, establishing a synergistic mechanism to maximize the synchronous network activity.
Astroglial Connexin43 as a Potential Target for a Mood Stabiliser

Motohiro Okada,Tomoka Oka,Misaki Nakamoto,Kouji Fukuyama,Takashi Shiroyama

DOI: https://doi.org/10.3390/ijms22010339

IF: 5.6

2020-12-30

International Journal of Molecular Sciences

Abstract:Mood disorders remain a major public health concern worldwide. Monoaminergic hypotheses of pathophysiology of bipolar and major depressive disorders have led to the development of monoamine transporter-inhibiting antidepressants for the treatment of major depression and have contributed to the expanded indications of atypical antipsychotics for the treatment of bipolar disorders. In spite of psychopharmacological progress, current pharmacotherapy according to the monoaminergic hypothesis alone is insufficient to improve or prevent mood disorders. Recent approval of esketamine for treatment of treatment-resistant depression has attracted attention in psychopharmacology as a glutamatergic hypothesis of the pathophysiology of mood disorders. On the other hand, in the last decade, accumulated findings regarding the pathomechanisms of mood disorders emphasised that functional abnormalities of tripartite synaptic transmission play important roles in the pathophysiology of mood disorders. At first glance, the enhancement of astroglial connexin seems to contribute to antidepressant and mood-stabilising effects, but in reality, antidepressive and mood-stabilising actions are mediated by more complicated interactions associated with the astroglial gap junction and hemichannel. Indeed, several depressive mood-inducing stress stimulations suppress connexin43 expression and astroglial gap junction function, but enhance astroglial hemichannel activity. On the other hand, monoamine transporter-inhibiting antidepressants suppress astroglial hemichannel activity and enhance astroglial gap junction function, whereas several non-antidepressant mood stabilisers activate astroglial hemichannel activity. Based on preclinical findings, in this review, we summarise the effects of antidepressants, mood-stabilising antipsychotics, and anticonvulsants on astroglial connexin, and then, to establish a novel strategy for treatment of mood disorders, we reveal the current progress in psychopharmacology, changing the question from “what has been revealed?” to “what should be clarified?”.

biochemistry & molecular biology,chemistry, multidisciplinary
Blocking Two-Pore Domain Potassium Channel TREK-1 Inhibits the Activation of A1-Like Reactive Astrocyte Through the NF-κB Signaling Pathway in a Rat Model of Major Depressive Disorder

Ting Cong,Ye Sun,Yitong Zhou,Haikuo Wu,Liya Li,Zhenchen Chu,Xue Chen,Jinying Li,Danmei Zhao,Yanfang Wang,Yingxin Liu,Shengming Yin,Zhaoyang Xiao

DOI: https://doi.org/10.1007/s11064-023-03857-4

Abstract:Major depressive disorder (MDD) refers to a widespread psychiatric disorder. Astrocytes play a pivotal role in regulating inflammation which is a well-acknowledged key component in depression pathogenesis. However, the effects of the neuroinflammation-inducing A1-like astrocytes on MDD are still unknown. TWIK-related K+ channel 1 (TREK-1) has been demonstrated to regulate the action of antidepressants. Nevertheless, its mechanisms and effects on A1-like astrocyte stimulation in MDD are not clear. Therefore, we conducted in vivo and in vitro experiments using TREK-1 specific inhibitor spadin. In vivo, rats were subjected to a 6-week chronic unpredictable mild stress (CUMS) followed by spadin treatment. Behavioral tests were employed to surveil depressive-like behaviors. Hippocampal proteomic analysis was carried out with the purpose of identifying differentially expressed proteins after CUMS and spadin treatments. In vitro, astrocyte-conditioned medium and spadin were used to treat rat astrocyte cell line. The activated microglia, inflammatory factors, A1 astrocyte markers, and activated nuclear factor kappa B (NF-κB) pathway were later analyzed using immunofluorescence, western blot, and RT-qPCR. Our findings indicated that blockage of TREK-1 reduced CUMS-induced depressive-like behavior in rats, inhibited the microglial stimulation, reduced inflammatory factor levels, and suppressed the activation of A1-like reactive astrocytes in the hippocampus. We also verified that the suppression of A1-like astrocytes by spadin necessitated the NF-κB pathway. According to the findings, blocking TREK-1 inhibited the activation of A1-like reactive astrocytes via the NF-κB signaling pathway in MDD. Our study preliminarily identifies a novel antidepressant mechanism of TREK-1 action and provides a therapeutic path for MDD.
HCN channel inhibitor induces ketamine-like rapid and sustained antidepressant effects in chronic social defeat stress model

Min Cai,Yingbo Zhu,Mary Regis Shanley,Carole Morel,Stacy M Ku,Hongxing Zhang,Yuan Shen,Allyson K Friedman,Ming-Hu Han

DOI: https://doi.org/10.1016/j.ynstr.2023.100565

2023-08-19

Abstract:Repeated, long-term (weeks to months) exposure to standard antidepressant medications is required to achieve treatment efficacy. In contrast, acute ketamine quickly improves mood for an extended time. Recent work implicates that hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are involved in mediating ketamine's antidepressant effects. In this study, we directly targeted HCN channels and achieved ketamine-like rapid and sustained antidepressant efficacy. Our in vitro electrophysiological recordings first showed that HCN inhibitor DK-AH 269 (also called cilobradine) decreased the pathological HCN-mediated current (Ih) and abnormal hyperactivity of ventral tegmental area (VTA) dopamine (DA) neurons in a depressive-like model produced by chronic social defeat stress (CSDS). Our in vivo studies further showed that acute intra-VTA or acute systemic administration of DK-AH 269 normalized social behavior and rescued sucrose preference in CSDS-susceptible mice. The single-dose of DK-AH 269, both by intra-VTA microinfusion and intraperitoneal (ip) approaches, could produce an extended 13-day duration of antidepressant-like efficacy. Animals treated with acute DK-AH 269 spent less time immobile than vehicle-treated mice during forced swim test. A social behavioral reversal lasted up to 13 days following the acute DK-AH 269 ip injection, and this rapid and sustained antidepressant-like response is paralleled with a single-dose treatment of ketamine. This study provides a novel ion channel target for acutely acting, long-lasting antidepressant-like effects.
KCNQ channel openers reverse depressive symptoms via an active resilience mechanism

Allyson K. Friedman,Barbara Juarez,Stacy M. Ku,Hongxing Zhang,Rhodora C. Calizo,Jessica J. Walsh,Dipesh Chaudhury,Song Zhang,Angel Hawkins,David M. Dietz,James W. Murrough,Maria Ribadeneira,Erik H. Wong,Rachael L. Neve,Ming-Hu Han

DOI: https://doi.org/10.1038/ncomms11671

IF: 16.6

2016-05-24

Nature Communications

Abstract:Less than half of patients suffering from major depressive disorder, a leading cause of disability worldwide, achieve remission with current antidepressants, making it imperative to develop more effective treatment. A new therapeutic direction is emerging from the increased understanding of natural resilience as an active stress-coping process. It is known that potassium (K+) channels in the ventral tegmental area (VTA) are an active mediator of resilience. However, no druggable targets have been identified to potentiate active resilience mechanisms. In the chronic social defeat stress model of depression, we report that KCNQ-type K+ channel openers, including FDA-approved drug retigabine (ezogabine), show antidepressant efficacy. We demonstrate that overexpression of KCNQ channels in the VTA dopaminergic neurons and either local infusion or systemic administration of retigabine normalized neuronal hyperactivity and depressive behaviours. These findings identify KCNQ as a target for conceptually novel antidepressants that function through the potentiation of active resilience mechanisms.

multidisciplinary sciences
Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice

Justin S Catches,Jian Xu,Anis Contractor

DOI: https://doi.org/10.1016/j.bbr.2011.12.026

2012-03-17

Abstract:There is a clear link between dysregulation of glutamatergic signaling and mood disorders. Genetic variants in the glutamate receptor gene GRIK4, which encodes the kainate receptor subunit GluK4, alter the susceptibility for depression, bipolar disorder and schizophrenia. Here we demonstrate that Grik4(-/-) mice have reduced anxiety and an antidepressant-like phenotype. In the elevated zero-maze, a test for anxiety and risk taking behavior, Grik4(-/-) mice spent significantly more time exploring the open areas of the maze. In anxiogenic tests of marble-burying and novelty-induced suppression of feeding, anxiety-like behavior was consistently reduced in knockout animals. In the forced swim test, a test of learned helplessness that is used to determine depression-like behavior, knockout mice demonstrated significantly less immobility suggesting that Grik4 ablation has an antidepressant-like effect. Finally, in the sucrose preference test, a test for anhedonia in rodents, Grik4(-/-) mice demonstrated increased sucrose preference. Expression of the GluK4 receptor subunit in the forebrain is restricted to the CA3 region of the hippocampus and dentate gyrus regions where KARs are known to modulate synaptic plasticity. We tested whether Grik4 ablation had effects on mossy fiber (MF) plasticity and found there to be a significant impairment in LTP likely through a loss of KAR modulation of excitability of the presynaptic MF axons. These studies demonstrate a clear anxiolytic and antidepressant phenotype associated with ablation of Grik4 and a parallel disruption in hippocampal plasticity, providing support for the importance of this receptor subunit in mood disorders.
Potassium Release From the Habenular Astrocytes Induces Depressive-Like Behaviors in Mice

Hidenori Aizawa,Miho Matsumata,Laura Ayaka Noguera Oishi,Fumie Nishimura,Deepa Kamath Kasaragod,Xintong Yao,Wanqin Tan,Tomomi Aida,Kohichi Tanaka

DOI: https://doi.org/10.1002/glia.24647

2024-11-29

Glia

Abstract:The habenula has been implicated in psychiatric disorders such as depression, primarily because of its role in the modulation of the dopaminergic and serotonergic systems, which play a role in the pathophysiology of these disorders. Despite growing evidence supporting the role of the habenula in behavioral regulation, the process by which neural cells develop in the habenula remains elusive. Since the habenular anlage is found in the prosomere 2 domain expressing transcription factor Dbx1 in mouse embryos, we hypothesized that the Dbx1-expressing prosomere domain is a source of astrocytes that modulate neuronal activity in the habenula. To address this, we examined the cell lineage generated from Dbx1-expressing cells in male mice using tamoxifen-inducible Cre recombinase under the control of the Dbx1 promoter. Perinatal induction of Cre activity labeled cells migrating radially from the ventricular zone to the pial side of the habenular anlage, and eventually showed astrocyte-like morphology with expression of the marker protein, S100β, for mature astrocytes in the habenula of the adult mouse. Photostimulation of astrocytes expressing ChR2 released potassium ions into the extracellular space, which in turn excited the neurons with an increased firing rate in the lateral habenula. Finally, photostimulation of habenular astrocytes exacerbated depression-like phenotypes with reduced locomotor activity, exaggerated despair behavior and impaired sucrose preference in open-field, tail suspension and sucrose preference tests, respectively. These results indicated that the Dbx1-expressing perinatal domain generated astrocytes that modulated neuronal activity via the regulation of extracellular potassium levels.
Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant

Hung-Tsung Hsiao,Jeffrey Chi-Fei Wang,Sheng-Nan Wu

DOI: https://doi.org/10.3390/biomedicines10061318

IF: 4.757

2022-06-04

Biomedicines

Abstract:Vortioxetine (VOR) is recognized to exert antidepressant actions. However, whether this drug modifies ionic currents in excitable cells remains unclear. The aim of this study was to explore the electrophysiological effects of VOR and other related compounds in pituitary GH3 cells and in Neuro-2a cells. VOR suppressed the delayed-rectifier K+ current (IK(DR)) in a concentration-, time-, and state-dependent manner. Effective IC50 values needed to inhibit peak and sustained IK(DR) were computed to be 31.2 and 8.5 μM, respectively, while the KD value estimated from minimal binding scheme was 7.9 μM. Cell exposure to serotonin (10 μM) alone failed to alter IK(DR), while fluoxetine (10 μM), a compound structurally similar to VOR, mildly suppressed current amplitude. In continued presence of VOR, neither further addition of propranolol nor risperidone reversed VOR-mediated inhibition of IK(DR). Increasing VOR concentration not only depressed IK(DR) conductance but also shifted toward the hyperpolarized potential. As the VOR concentration was raised, the recovery of IK(DR) block became slowed. The IK(DR) activated by a downsloping ramp was suppressed by its presence. The inhibition of IK(DR) by a train pulse was enhanced during exposure to VOR. In Neuro-2a cells, this drug decreased IK(DR). Overall, inhibitory effects of VOR on ionic currents might constitute another underlying mechanism of its actions.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Functional contribution of astrocytic Kir4.1 channels to spasticity after spinal cord injury

Tony Barbay,Emilie Pecchi,Jose Jorge Ramirez Franco,Anton Ivanov,Frederic Brocard,Nathalie Rouach,Remi BOS

DOI: https://doi.org/10.1101/2024.10.11.617793

2024-10-12

Abstract:Spasticity, a prevalent motor issue characterized by network hyperexcitability, causes pain and discomfort, with existing treatments offering limited relief. While past research has focused on neuronal factors, the role of astrocytes in spasticity has been overlooked. This study explores the potential of restoring astrocytic potassium (K+) uptake to reduce spasticity following SCI. Astrocytes buffer extracellular K+ via Kir4.1 channels, preventing neuronal hyperexcitability. Following spinal cord injury (SCI), Kir4.1 levels decrease at the injury site, though the consequences and mechanisms of this reduction within the motor output area have not been investigated. Utilizing advanced techniques, we demonstrate that lumbar astrocytes in a juvenile thoracic SCI mouse model switch to reactive phenotype, displaying morpho-functional and pro-inflammatory changes. These astrocytes also experience NBCe1-mediated intracellular acidosis, leading to Kir4.1 dysfunction and impaired K+ uptake. Enhancing Kir4.1 function reduces spasticity in SCI mice, revealing new therapeutic targets for neurological diseases associated with neuronal hyperexcitability.

Neuroscience

Dam antidepressants

Regulation of gap junctional communication by astrocytic mitochondrial K(ATP) channels following neurotoxin administration in in vitro and in vivo models.

Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes

Astrocytes Contribute to Regulation of Extracellular Calcium and Potassium in the Rat Cerebral Cortex During Spreading Depression

Pharmacological Inhibition of Kir4.1 Evokes Rapid-Onset Antidepressant Responses

Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression

Kir6.1/K-ATP channel in astrocytes is an essential negative modulator of astrocytic pyroptosis in mouse model of depression

Amoxapine Inhibits the Delayed Rectifier Outward K+ Current in Mouse Cortical Neurons Via Camp/protein Kinase A Pathways

Lack of Rapid Antidepressant Effects of Kir4.1 Channel Inhibitors in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine.

The Potassium Channel KCa3.1 Constitutes a Pharmacological Target for Astrogliosis Associated with Ischemia Stroke.

Inhibition of astroglial hemichannels prevents synaptic transmission decline during spreading depression

Neuromodulation of Astrocytic K+ Clearance

Astroglial Connexin43 as a Potential Target for a Mood Stabiliser

Blocking Two-Pore Domain Potassium Channel TREK-1 Inhibits the Activation of A1-Like Reactive Astrocyte Through the NF-κB Signaling Pathway in a Rat Model of Major Depressive Disorder

HCN channel inhibitor induces ketamine-like rapid and sustained antidepressant effects in chronic social defeat stress model

KCNQ channel openers reverse depressive symptoms via an active resilience mechanism

Genetic ablation of the GluK4 kainate receptor subunit causes anxiolytic and antidepressant-like behavior in mice

Potassium Release From the Habenular Astrocytes Induces Depressive-Like Behaviors in Mice

Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant

Functional contribution of astrocytic Kir4.1 channels to spasticity after spinal cord injury